BJL
IRWD icon

Brighton Jones LLC’s Ironwood Pharmaceuticals IRWD Stock Holding History

Brighton Jones LLC’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$168K Sell
39,881
-158
-0.4% -$609 ﹤0.01% 1270
2026
Q1 		$141K Buy
+40,039
New +$164K ﹤0.01% 1113
2025
Q4 		– Sell
-33,071
Closed -$43.3K – 493
2025
Q3 		$43.3K Buy
33,071
+2,646
+9% +$2.74K ﹤0.01% 1008
2025
Q2 		$21.8K Buy
+30,425
New +$23.9K ﹤0.01% 917

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Brighton Jones LLC's IRWD Position: Q2 2026 in Review

Brighton Jones LLC reduced its Ironwood Pharmaceuticals (IRWD) stake by 0.39% in Q2 2026, selling an estimated $609 and leaving 39,881 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #1270.

Brighton Jones LLC first reported a position in IRWD in Q2 2025 and has held it in 4 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Brighton Jones LLC held 39,881 shares of Ironwood Pharmaceuticals worth $168K as of Q2 2026.
  • Brighton Jones LLC sold 158 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $609.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1270 holding.
  • Brighton Jones LLC first reported a position in Ironwood Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.